ѻý

<ѻý class="page-title">Oncology/Hematology

Lung Cancer

<ѻý class="page-description">

More in Lung Cancer

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

News, features, and commentary about cancer-related issues

Nov 01, 2024
Onco Break over a computer rendering of a cancer cell.
Year in Review: Non-Small Cell Lung Cancer

A look back at some of the newsworthy developments of 2024

Nov 01, 2024
2024 YEAR IN REVIEW NSCLC over a computer rendering of monoclonal antibodies attacking lung cancer cells.
Early Smoking Cessation After Cancer Diagnosis Tied to Better Survival

Largest survival benefit observed in patients who entered a cessation program within 6 months

Oct 31, 2024
A close up photo of cigarettes sticking out of a pack.
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

-- News, features, and commentary about cancer-related issues

Oct 18, 2024
Onco Break over a computer rendering of a cancer cell.
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

Debate highlights pros and cons of the new recommendation

Oct 11, 2024
CHEST over a photo of Boston Convention and Exhibition Center, Boston, MA.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone

Oct 10, 2024
A computer rendering of non-small cell lung cancer.
Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolism

Study raises questions about how to assess patient risk, experts say

Oct 08, 2024
CHEST over a photo of Boston Convention and Exhibition Center, Boston, MA.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

News, features, and commentary about cancer-related issues

Oct 04, 2024
Onco Break over a computer rendering of a cancer cell.
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Latest negative results emphasize "critical" aspect of immunotherapy timing

Oct 02, 2024
ASTRO over a photo of Walter E. Washington Convention Center in Washington, DC.
FDA Expands Approval of Osimertinib in Lung Cancer

EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy

Sep 25, 2024
FDA APPROVED osimertinib (Tagrisso) over a computer rendering of lung cancer.
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

Actual rates for 2021 lagged behind projections

Sep 25, 2024
A photo of test tubes of blood lying on a test form with CANCER stamped in red at the bottom.
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

News, features, and commentary about cancer-related issues

Sep 19, 2024
Onco Break over a computer rendering of a cancer cell.
Novel Agent Effective for Cancer Wasting Disorder

Cancer patients with cachexia added needed pounds with GDF-15 antibody

Sep 18, 2024
ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

News, features, and commentary about cancer-related issues

Sep 12, 2024
Onco Break over a computer rendering of a cancer cell.
More in Lung Cancer

1.00 CME Credits
Breakthrough Immunotherapies Transforming Early-Stage NSCLC Treatment

1.00 CME Credits
Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment

1.00 CME Credits
Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies From Leading Experts

1.00 CME Credits
JAK Inhibitors and Beyond: Assessing Novel Approaches in Myelofibrosis Treatment

0.50 CME Credits
Evidence-Based Multidisciplinary Management of Cirrhosis in Hepatocellular Carcinoma

1.00 CME Credits
Decoding Complex Chronic Lymphocytic Leukemia Cases: An Expert TheraTalk

1.00 CME Credits
Lung Cancer: Applying Evidence-Based Guidelines to Biomarker Driven Treatment Selection in Perioperative Settings

1.50 CME Credits
Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL